137 related articles for article (PubMed ID: 1680183)
1. Protection of acetylcholinesterase by meptazinol in mice exposed to di-isopropyl fluorophosphate. Comparison with physostigmine.
Galli A; Mori F
J Pharm Pharmacol; 1991 May; 43(5):366-9. PubMed ID: 1680183
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of 1,2,3,4-tetrahydro-9-aminoacridine (THA) as a pretreatment drug for protection of mice from acute diisopropylfluorophosphate (DFP) intoxication.
Galli A; Mori F
Arch Toxicol; 1991; 65(4):330-4. PubMed ID: 1953352
[TBL] [Abstract][Full Text] [Related]
3. Protection against diisopropylfluorophosphate intoxication by meptazinol.
Galli A; Mazri A
Toxicol Appl Pharmacol; 1988 Sep; 95(3):388-96. PubMed ID: 3188007
[TBL] [Abstract][Full Text] [Related]
4. Prevention of physostigmine-induced lethality by the opioid analgesic meptazinol in the mouse.
Bottoncetti A; Galli A
Br J Pharmacol; 1987 Jun; 91(2):299-306. PubMed ID: 3607358
[TBL] [Abstract][Full Text] [Related]
5. Prevention of diisopropylfluorophosphate (DFP)-induced lethality by meptazinol and 9-amino-tetrahydroacridine (THA) in the mouse.
Galli A; Mazri A; Mori F; Cecchini L; Lucherini M
Acta Physiol Hung; 1990; 75 Suppl():125-6. PubMed ID: 2371839
[No Abstract] [Full Text] [Related]
6. Efficacy of antidotes and their combinations in the treatment of acute carbamate poisoning in rats.
Stojiljković MP; Škrbić R; Jokanović M; Kilibarda V; Bokonjić D; Vulović M
Toxicology; 2018 Sep; 408():113-124. PubMed ID: 30176331
[TBL] [Abstract][Full Text] [Related]
7. In vitro protection of acetylcholinesterase and butyrylcholinesterase by tetrahydroaminoacridine. Comparison with physostigmine.
Galli A; Mori F; Gori I; Lucherini M
Biochem Pharmacol; 1992 Jun; 43(11):2427-33. PubMed ID: 1610407
[TBL] [Abstract][Full Text] [Related]
8. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine.
Yamada S; Isogai M; Okudaira H; Hayashi E
J Pharmacol Exp Ther; 1983 Aug; 226(2):519-25. PubMed ID: 6875862
[TBL] [Abstract][Full Text] [Related]
9. In-vitro and in-vivo protection of acetylcholinesterase by eseroline against inactivation by diisopropyl fluorophosphate and carbamates.
Galli A; Malmberg Aiello P; Renzi G; Bartolini A
J Pharm Pharmacol; 1985 Jan; 37(1):42-8. PubMed ID: 2858526
[TBL] [Abstract][Full Text] [Related]
10. Protection against diisopropylfluorophosphate intoxication by pyridostigmine and physostigmine in combination with atropine and mecamylamine.
Harris L; Stitcher D
Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):64-9. PubMed ID: 6493352
[TBL] [Abstract][Full Text] [Related]
11. The effect of pyridostigmine and physostigmine on acute toxicity of diisopropyl fluorophosphate in rats.
Husain K; Vijayaraghavan R; Marjit DN
Arh Hig Rada Toksikol; 1990 Mar; 41(1):19-24. PubMed ID: 2396896
[TBL] [Abstract][Full Text] [Related]
12. Toxicity and characterization of cholinesterase-inhibition induced by diisopropyl fluorophosphate in Artemia salina larvae.
Sánchez-Fortún S; Barahona MV
Ecotoxicol Environ Saf; 2009 Mar; 72(3):775-80. PubMed ID: 18191451
[TBL] [Abstract][Full Text] [Related]
13. In vivo protection of diisopropylphosphorofluoridate (DFP) poisoning by three bis-quaternary 2 -(hydroxyimino) -N -(pyridin-3-yl) acetamide derivatives in Swiss mice.
Kumar P; Swami D; Karade HN; Acharya J; Jatav PC; Kumar A; Meena MK
Cell Mol Biol (Noisy-le-grand); 2014 Oct; 60(3):53-9. PubMed ID: 25346249
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo action of diisopropylfluorophosphate, of atropine and their synergism on acetylcholinesterase activity.
Molinengo L; Ghi P
Pharmacology; 1989; 39(3):154-9. PubMed ID: 2587621
[TBL] [Abstract][Full Text] [Related]
15. Acetylcholinesterase protection and the anti-diisopropylfluorophosphate efficacy of E2020.
Galli A; Mori F; Benini L; Cacciarelli N
Eur J Pharmacol; 1994 Apr; 270(2-3):189-93. PubMed ID: 8039548
[TBL] [Abstract][Full Text] [Related]
16. Protection by a transdermal patch containing physostigmine and procyclidine of soman poisoning in dogs.
Kim WS; Cho Y; Kim JC; Huang ZZ; Park SH; Choi EK; Shin S; Nam SY; Kang JK; Hwang SY; Kim YB
Eur J Pharmacol; 2005 Nov; 525(1-3):135-42. PubMed ID: 16256978
[TBL] [Abstract][Full Text] [Related]
17. Organophosphate-induced convulsions and prevention of neuropathological damages.
Tuovinen K
Toxicology; 2004 Mar; 196(1-2):31-9. PubMed ID: 15036754
[TBL] [Abstract][Full Text] [Related]
18. Recovery of acetylcholinesterase activity after acute organophosphate treatment of CNS reaggregate cultures.
Wehner JM; Smolen A; Smolen TN; Murphy C
Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 1):1104-9. PubMed ID: 4092872
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological estimation of the actions of acetylcholinesterase inhibitors on acetylcholine receptor and cholinesterase in physically isolated Aplysia neurones.
Oyama Y; Hori N; Evans ML; Allen CN; Carpenter DO
Br J Pharmacol; 1989 Mar; 96(3):573-82. PubMed ID: 2720293
[TBL] [Abstract][Full Text] [Related]
20. Effects of PAM, proPAM, and DFP on behavior, thermoregulation, and brain AChE in rats.
Kenley RA; Howd RA; Uyeno ET
Pharmacol Biochem Behav; 1982 Nov; 17(5):1001-8. PubMed ID: 7178195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
